Back to basics: PCSK9 as a new target for the LDL receptor

dc.creatorCorral, Pablo
dc.date2014
dc.date.accessioned2026-03-06T20:29:57Z
dc.date.available2026-03-06T20:29:57Z
dc.descriptionForty years after Goldstein and Brown's discovery of the low density lipoprotein receptor (LDLR) and 25 years after the introduction of the statins, a cornerstone of the atherosclerotic disease management, the view of the scientific community studying the process of atherosclerosis turns once again to the LDLR through the action mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9). The assessment of genetic polymorphism with unexpected results in large studies revived the hypothesis about the important role of high density lipoprotein cholesterol (HDL-C) in lipoprotein metabolism; the apparent eternal debate about the contribution of triglycerides (TG) and their remnants to the phenomenon of atherogenesis. Such advances have lead to the re-prioritization of LDL management as a central and primary objective towards the prevention of the morbidity and mortality main cause in the Western world, atherosclerosis. Once again, we return to the discovery that led Goldstein and Brown to a Nobel Prize in 1985, the LDLR1; now seeking to avoid its degradation through the knowledge and understanding of PCSK9 action mechanism.
dc.descriptionFil: Corral, Pablo. Universidad FASTA. Facultad de Ciencias MƩdicas; Argentina.
dc.formatapplication/pdf
dc.identifier.citationCorral P. (2014). Back to basics: PCSK9 as a new target for the LDL receptor. Arquivos brasileiros de cardiologia, 102(1), e5–e8. https://doi.org/10.5935/abc.20130248
dc.identifier.issn1678-4170
dc.identifier.urihttps://dspace.ufasta.edu.ar/handle/123456789/87902
dc.languagespa
dc.publisherArquivos brasileiros de cardiologia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licences/by-nc-nd/3.0/deed.es_AR
dc.sourceArquivos brasileiros de cardiologia, 102(1), e5–e8.
dc.subjectReceptores
dc.subjectLDL
dc.subjectProteĆ­na PCSK9
dc.subjectPolimorfismo
dc.subjectAterosclerosis
dc.titleBack to basics: PCSK9 as a new target for the LDL receptor
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artĆ­culo
dc.typeinfo:eu-repo/semantics/acceptedVersion

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Corral_2014_1678-4170.pdf
Size:
306.97 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: